Publicacións en colaboración con investigadores/as de Universidade da Coruña (98)

2024

  1. Challenges in the Implementation of the Spanish Consensus on the Reduction of Oral Corticosteroids: Insights From the Medical Community

    Open Respiratory Archives, Vol. 6, Núm. 3

  2. Combined Treatment Scenarios for Patients With Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps. A Proposal From GEMA-POLINA Task Force

    Open Respiratory Archives, Vol. 6, Núm. 3

  3. Home Respiratory Therapies: SEPAR Technical Document for Institutional Decision Support

    Open Respiratory Archives, Vol. 6, Núm. 2

  4. Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA)

    European Journal of Internal Medicine, Vol. 128, pp. 45-52

  5. Spanish Consensus on Remission in Asthma (REMAS)

    Archivos de Bronconeumologia, Vol. 60, Núm. 8, pp. 503-509

2023

  1. A Study of the Prevalence of Asthma in the General Population in Spain

    Open Respiratory Archives, Vol. 5, Núm. 2

  2. Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study

    Respiratory research, Vol. 24, Núm. 1, pp. 235

  3. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  4. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  5. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  6. Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma

    Frontiers in Pharmacology, Vol. 14

  7. Quality indicators in the rational management of severe asthma: A Spanish multidisciplinary consensus

    Journal of Healthcare Quality Research, Vol. 38, Núm. 5, pp. 277-283

  8. REDES Study: Mepolizumab Is Effective in Patients With Severe Asthma and Comorbid Nasal Polyps

    Journal of Investigational Allergology and Clinical Immunology

  9. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  10. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors

    Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82

  11. Telemedicine and severe asthma in our environment: Views on the experience of professionals and suggestions to make it a reality

    Open Respiratory Archives, Vol. 5, Núm. 3

  12. The ATLAS ASMA Study: Assessing the Impact of Asthma on Patients’ Life – The Spanish Patients’ Perspective

    Journal of Asthma and Allergy, Vol. 16, pp. 461-471

  13. Transition of Adolescents With Severe Asthma From Pediatric to Adult Care in Spain: The STAR Consensus

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 179-189

  14. Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain

    Open Respiratory Archives, Vol. 5, Núm. 3

  15. Validation of the Algorithm for the Monitoring and Control of Asthma Through Telemedicine: The COMETA Project

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 223-225